Predictive Modeling and Explainable AI for Veterinary Safety Profiles, Residue Assessment, and Health Outcomes Using Real-World Data and Physicochemical Properties
Not on the map. Why?
Abstract (arXiv)
The safe use of pharmaceuticals in food-producing animals is vital to protect animal welfare and human food safety. Adverse events (AEs) may signal unexpected pharmacokinetic or toxicokinetic effects, increasing the risk of violative residues in the food chain. This study introduces a predictive framework for classifying outcomes (Death vs. Recovery) using ~1.28 million reports (1987-2025 Q1) from the U.S. FDA's OpenFDA Center for Veterinary Medicine. A preprocessing pipeline merged relational tables and standardized AEs through VeDDRA ontologies. Data were normalized, missing values imputed, and high-cardinality features reduced; physicochemical drug properties were integrated to capture chemical-residue links. We evaluated supervised models, including Random Forest, CatBoost, XGBoost, ExcelFormer, and large language models (Gemma 3-27B, Phi 3-12B). Class imbalance was addressed, such as undersampling and oversampling, with a focus on prioritizing recall for fatal outcomes. Ensemble methods(Voting, Stacking) and CatBoost performed best, achieving precision, recall, and F1-scores of 0.95. Incorporating Average Uncertainty Margin (AUM)-based pseudo-labeling of uncertain cases improved minority-class detection, particularly in ExcelFormer and XGBoost. Interpretability via SHAP identified biologically plausible predictors, including lung, heart, and bronchial disorders, animal demographics, and drug physicochemical properties. These features were strongly linked to fatal outcomes. Overall, the framework shows that combining rigorous data engineering, advanced machine learning, and explainable AI enables accurate, interpretable predictions of veterinary safety outcomes. The approach supports FARAD's mission by enabling early detection of high-risk drug-event profiles, strengthening residue risk assessment, and informing regulatory and clinical decision-making.
Key facts. Cited by 3 papers in the map (data through 7 Oct 2026). Builds on 6 of its 35 references that are in the map. First posted on arXiv 1 Oct 2025.
Builds on
6 of 35 references.
References · 6
- 2017A Unified Approach to Interpreting Model Predictionscited by 6,488
- 2018Consistent Individualized Feature Attribution for Tree Ensemblescited by 279
- 2020Identifying Mislabeled Data using the Area Under the Margin Rankingcited by 259
- 2023ExcelFormer: A neural network surpassing GBDTs on tabular datacited by 33
- 2025AutoPK: Leveraging LLMs and a Hybrid Similarity Metric for Advanced Retrieval of Pharmacokinetic Data from Complex Tables and Documentscited by 4
- 2024Integrating Protein Sequence and Expression Level to Analysis Molecular Characterization of Breast Cancer Subtypescited by 2
Built on by
Citing papers per year: 2025: 2; 2026: 1.
3 papers.
- 2025HySim-LLM: Embedding-Weighted Fine-Tuning Bounds and Manifold Denoising for Domain-Adapted LLMscited by 1
- 2025Interpretable Machine Learning for Predicting Startup Funding, Patenting, and Exitscited by 1
- 2026Unsupervised Pattern Analysis in Japanese Veterinary Toxicology: A Regulatory-Compliant Framework for Cross-Species Risk Assessmentcited by 0
- 2026Unsupervised Pattern Analysis in Japanese Veterinary Toxicology: A Regulatory-Compliant Framework for Cross-Species Risk Assessment4 Jun 2026
- 2025Interpretable Machine Learning for Predicting Startup Funding, Patenting, and Exits10 Oct 2025
- 2025HySim-LLM: Embedding-Weighted Fine-Tuning Bounds and Manifold Denoising for Domain-Adapted LLMs9 Oct 2025